DelveInsight Business Research LLP

DelveInsight’s “House Dust Mite Allergy Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the House Dust Mite Allergy, historical and forecasted epidemiology as well as the House Dust Mite Allergy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Key Highlights for House Dust Mite Allergy 

• Key Companies working in the House Dust Mite Allergy Market are ASIT Biotech S.A, Circassia Limited and many others 

• Key Therapies included in the House Dust Mite Allergy market are as follows Histamine, Azelastine and many others 

• The Market size for the House Dust Mite Allergy market is USD XX million 

• The CAGR for the House Dust Mite Allergy market is XX%.

House Dust Mite Allergy Overview

Dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Signs of dust mite allergy include those common to hay fever, such as sneezing and runny nose. Many people with dust mite allergy also experience signs of asthma, such as wheezing and difficulty breathing.

The house dust mite is a predominant source of indoor aeroallergens. Some of the allergic diseases that have been associated with the HDM are allergic rhinoconjunctivitis, allergic asthma, and atopic eczema. The best treatment strategy for allergic rhinitis consists of allergen avoidance first, in junction with pharmacotherapy and allergen immunotherapy (AIT).[2] The appropriate pharmacotherapy consists of antihistamines, leukotriene receptor antagonists, and inhaled or intranasal corticosteroids (ICS). All these treatments are effective and safe, but unfortunately, haven’t proved to change the course of HDM related allergic diseases.

House Dust Mite Allergy Epidemiology Insights 

• Dust mite allergy is a prevalent form of allergy. It affects 20 million people across The United States of America. Being ubiquitous, house dust mites are found all across the world. Around 84 percent of USA households have been detected with the presence of house dust mites. In industrialized areas, like Germany, 1 out of every four people are affected by dust mite allergy. Combined, allergic rhinitis (AR) and asthma affect up to 800 million people worldwide, according to the World Health Organization (WHO).

• Up to two-thirds of children with asthma and up to 1/2 of adults who have asthma also suffer from allergies. Of these patients who suffer from asthma and allergies, about 40%-85% of them are allergic to the House Dust Mite Allergy , this trend is observed all over America, Europe, south-east Asia, and Australia. Around 5 to 30 percent of the general population show house dust mite sensitivity to skin test reactivity.

• Ninety-seven percent of people with dust mite allergy are sensitized to the allergen Der p 1. Der p 11 has been most frequently associated with atopic dermatitis. 70 percent of the people with dust mite allergy have been recently found to be sensitized to Der p 23 allergen. To date, 24 allergens associated with house dust mite have been iden

Click here to learn more about the House Dust Mite Allergy Market Landscape

The Report Covers the House Dust Mite Allergy Epidemiology Segmented by:

• House Dust Mite Allergy prevalent cases 

• House Dust Mite Allergy incident cases 

• House Dust Mite Allergy treatment cases 

• Post- Polycythemia Vera Myelofibrosis diagnosed cases 

House Dust Mite Allergy Market Outlook

The House Dust Mite Allergy market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted House Dust Mite Allergy market trends by analyzing the impact of current House Dust Mite Allergy therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the House Dust Mite Allergy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated House Dust Mite Allergy market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the House Dust Mite Allergy market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the House Dust Mite Allergy Market

• ASIT Biotech S.A, 

• Circassia Limited 

And many others 

 House Dust Mite Allergy Therapies Covered and Analyzed in the Report

• Histamine, 

• Azelastine 

And many others 

Learn about the Key Companies and Emerging Therapies in the Post – Polycythemia Vera Myelofibrosis Market 

Table of Contents 

1. Key Insights 

2. House Dust Mite Allergy Introduction 

3. Executive Summary of House Dust Mite Allergy       –     

4. Disease Background and Overview

5. Epidemiology and patient population

6. House Dust Mite Allergy Emerging Therapies

7. House Dust Mite Allergy Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ House Dust Mite Allergy Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services